Percutaneous tracheostomy is commonly performed in the intensive care unit. This study assesses the long-term outcomes following percutaneous tracheostomy using the Griggs technique. We carried out a prospective observational cohort study. Two hundred and eight patients who had undergone percutaneous tracheostomy between 1 September 1996 and 31 July 2000 and who were alive at least six months following the procedure, were included in the study. Median follow-up was at 30 months. All patients were sent questionnaires regarding relevant symptoms. One hundred and six (51%) responded and were invited for further follow-up. Forty-three (20.6%) patients underwent scar evaluation by the investigators and 41/208 (19.7%) underwent spirometry. Of the responders, 38% complained of some degree of voice change and 12% complained of ongoing severe cough. Thirty-one per cent complained of shortness of breath, with more than half of these having concomitant heart or lung disease, which may explain this. Eighty-one per cent of patients had minimally visible or a visible but neat scar. Eight patients (8/41 (19.5%)) had some evidence of upper airway obstruction on spirometry, but only 2/41 (5% of patients) were symptomatic (stridor or shortness of breath).
Percutaneous tracheostomy is performed routinely in most ICUs. There are two frequently used techniques for the percutaneous dilatational tracheostomy. The first was described by Ciaglia 1, 2 , using the Seldinger technique to pass serial dilators of increasing sizes over a guidewire positioned in the trachea. The Griggs technique uses modified Howard-Kelly forceps to dilate the trachea over a guidewire, before insertion of the cannula 3 . More recently, Ciaglia has introduced a single dilator technique called the "Blue Rhino" 4 . Intraoperative and short-term postoperative complications of percutaneous tracheostomy have been studied extensively. Recent reports suggest a short-term complication rate of 7 to 22% [5] [6] [7] [8] . Long-term complications of percutaneous tracheostomy include laryngotracheal stenosis, tracheomalacia, voice change, tracheo-oesophageal fistula and cosmetic issues such as scarring and skin tethering 9, 10 . Most published studies have looked at patients who had undergone percutaneous dilatational tracheostomy using the Ciaglia technique. We present our follow-up of patients who have undergone percutaneous tracheostomy with the Griggs technique, using a questionnaire, scar evaluation and spirometry.
METHODS
This study reviewed patients who underwent percutaneous tracheostomy using the Griggs kit (Portex, Hythe, Kent, U.K.) 3, 9 between September 1996 and August 2000 in this tertiary referral intensive care unit (ICU). The method by which percutaneous tracheostomies were performed is described elsewhere 9 . The procedures were carried out by experienced medical staff (consultants and registrars) in the ICU. Portex tracheostomy tubes (Sims Portex Ltd., Hythe, Kent) were used throughout this period with cuff pressures maintained at or below 30 cmH 2 O at all times.
Human Research Ethics Committee approval was granted for this study which comprised a questionnaire, visual examination of the scar and a flowvolume loop lung function test. Letters including an information sheet, a questionnaire and a consent form to participate in the study were sent out to all 208 surviving patients. The questionnaire asked patients to grade six symptoms as either absent (score A), mild (Score B), or severe (Score C). The symptoms elicited were pain, change in voice, shortness of breath, stridor, cough, and cosmetic appearance of scar.
Responders who consented were requested to return to the hospital for further review by the investigators, including scar examination. Assessment was graded as no, or minimally visible scar, score=0; visible but neat scar, score=1; obvious or ugly scar (including skin tethering), score=2; or tracheostomy in situ score=5. Following this review, patients underwent formal pulmonary function testing to assess upper airway dynamic function by inspiratory and expiratory flow-volume loops. These were obtained by a dedicated technician using a digital pneumotachograph (No. 4 Fleiss Digital Pneumotachograph, model 47303A; Hewlett Packard; Waltham, MD U.S.A.) and performed according to the American Thoracic Society guidelines 11 . Upper airway function was assessed in 41 patients by inspiratory and expiratory flow-volume loops. The flow-volume loops were evaluated initially by a pulmonology trainee (RS) and subsequently by a pulmonary physiologist, both blinded to findings of the questionnaire and clinical review. Three of the four criteria of Rotman et al were used to diagnose upper airway obstruction 12 . These were as follows: (1) forced inspiratory flow at 50% of vital capacity (FIF50) 100 l/min; (2) ratio of forced expiratory flow at 50% of vital capacity to the FIF50 (FEF50:FIF50) ≥1;
(3) ratio of the FEV1 (ml) to peak expiratory flow rate (l/min) (FEV1: PEFR) ≥10 ml.min.l -1 . We were technically unable to obtain the expired volume in 0.5 seconds and therefore could not calculate the ratio of the FEV1 to the expired volume in 0.5 seconds (FEV1:FEV0.5) >1.5. The experienced pulmonary physiologist reviewed the results and determined whether the flow-volume loops were "normal" or "abnormal".
Medical records for patients demonstrating signs of upper airway obstruction were reviewed for duration of translaryngeal intubation, episodes of re-intubation and duration of percutaneous tracheostomy insertion.
Data analysis
Descriptive statistics only are presented. Results are presented as mean ±SD.
RESULTS
Three hundred and twenty-three percutaneous tracheostomies were inserted from September 1996 to August 2000 using the Griggs kit. Of these, 208/323 (64%) were alive six months after hospital discharge and all of these were sent questionnaires and consent forms. One hundred and six (106/208 (51%)) patients replied to the questionnaires and a total of 43/208 (20.6%) consented for further review and returned to hospital for follow-up. Forty-one (41/208 (19.7%)) completed lung function tests.
Questionnaires
Sixty-two per cent of the 106/208 responders were male and 38% female.
The mean age was 55.5±18.1 years with a range of 15 to 81 years. The mean length of intubation prior to tracheostomy was 7.1 days ±3.8. The mean time to follow-up was 29.5 months ±12.3, with a median of 30 months and a range of 9 to 55 months. Two patients still had a tracheostomy in situ or an open tracheostomy wound at the time of review.
Patient responses to the questionnaires are summarized in Table 1 . Most patients (68%) were asymptomatic. Ten percent reported a major voice change, 10% complained of severe shortness of breath and 12% of troublesome cough. More than half the patients with shortness of breath and the patients with cough had concomitant heart or lung disease (congestive heart failure of any cause or chronic obstructive airways disease as determined by questionnaire, review of notes and history from patients at follow-up visit), which may explain these symptoms. Most patients (92%) rated their scar appearance as good or moderate. Only 6% described it as poor. 
Scar Evaluation
Forty-three patients, (43/208 (20.6%)), underwent scar evaluation by the investigators. The investigators were blinded as to the patients' description of their scars (i.e., the questionnaire findings). Mean and median time to follow-up for the group of subject who returned to the hospital for review were 31 and 34.5 months respectively.
Twelve (12/43 (28%)) patients had no or a minimally visible scar (score 0) ( Figure 1 ). Twenty-three (23/43 (53%)) had a visible but neat scar (score 1) ( Figure 2 ), and 8/43 (19%) had an obvious or ugly scar, including skin tethering (score 2) ( Figure 3 ). The mean score was 0.9. All but one of the eight patients with a score of 2 described their scar as good or moderate in the questionnaire.
Spirometry
Two patients who came for evaluation were too weak to perform flow-volume loops, leaving 41/208 (19.7%) patients who underwent spirometry. Twentynine (29/41 (71%)) patients produced entirely normal studies. Twelve (12/41 (29%)) patients showed abnormalities in one or more criteria, of which 4/41 (9.7%) had only an isolated borderline abnormality in FEF50%/FIF50% and 8/41 (19.5%) were definitely abnormal (see Table 2 ). Of these eight, only two complained of stridor or shortness of breath (patients #3 and #4). The rest were either asymptomatic or complained of only minor voice change or cough, making the rate of symptomatic upper airway obstruction 2/41 (5%). Mean and median time to follow-up of the eight patients with abnormal spirometry were 34.2 and 33.75 months respectively.
Five (62.5%) of the eight patients with abnormal studies had previously failed extubation in the ICU and had been re-intubated translaryngeally. The mean duration of translaryngeal intubation prior to tracheostomy was 8.9 days. The mean length of tracheostomy cannulation was 16.6 days.
DISCUSSION
In this study we have shown that 38% of patients complained of some degree of voice change and 31% complained of shortness of breath, more than half of which had heart or lung disease to explain this. Most patients had a minimally visible scar as evaluated by the investigators and most patients (94%) assessed their scar as good or moderate. Spirometry showed an abnormal inspiratory obstructive pattern in 8/41 (19.5%) patients, only two of whom (5%) were symptomatic. It is worth noting that five of these patients (5/8), had undergone re-intubation for failed extubation prior to tracheostomy insertion, which may have contributed to their spirometry findings.
Long-term complications of percutaneous tracheostomy have already been mentioned. One case of complete tracheal atresia following repeated percutaneous tracheostomy has also been described 13 . Studies evaluating the long-term complications of percutaneous tracheostomy have been few, partly because of the relatively high mortality rate in ICU patients and the difficulty in establishing subjective and objective criteria to define significant complications 14, 15 . Moreover, more studies have reported the long-term complications of the Ciaglia percutaneous dilatational technique 6,14-21 than the Griggs technique 9, [22] [23] [24] (Table 3 ). An additional difficulty in performing long-term follow-up studies is the preference for different techniques by different centres, making large scale, long-term comparative studies harder to achieve. Moreover, the direct cause of subjective or objective findings in patients who have survived a critical illness is difficult to determine. Prolonged translaryngeal intubation is associated with laryngeal stenosis and may be the cause of this finding at follow-up. Cuff pressure of the translaryngeal or tracheostomy tubes, which is not usually well documented, may also impact on the incidence of tracheal stenosis 5, 14 . Table 3 shows the reported long-term complication rates for the Ciaglia and Griggs techniques. McFarlane et al 17 reported four cases of laryngotracheal stenosis viewed on direct laryngoscopy nine days to two months post tracheostomy, but it was unclear whether these may have been caused by the previous endotracheal tube 25 . Law et al 14 studied 41 patients with a median follow-up time of 565 days. Their results showed that only four (10%) patients had more than 10% stenosis, all of them asymptomatic. Walz et al 20 looked at two dimensional X-ray examination of the trachea in 106 patients who had undergone a bronchoscopy-guided percutaneous tracheostomy using the Ciaglia technique. Fortythree per cent had more than 10% stenosis, but only one patient with more than 50% stenosis was symptomatic. Norwood et al 15 interviewed 100 patients following bronchoscopy-guided percutaneous dilatational tracheostomy with a median follow-up of 26 months. Forty-eight patients underwent tracheal CT scan evaluation and 38 underwent fibreoptic laryngotracheoscopy. Tracheal stenosis, defined as more than 10% stenosis on CT scan evaluation, was found in 31% of the patients, 21% having mild stenosis, 8.3% having moderate stenosis and 2% (1 patient) severe stenosis. Tracheal stenosis is symptomatic when 75% or more of the tracheal diameter is reduced 14 and objective findings of minimal or moderate stenosis may not be clinically significant. It should be noted that some authors regard a stenotic lesion of more than 10% of the tracheal lumen as significant 14, 19, 20 . Three of the fifteen patients (20%) with tracheal stenosis were symptomatic. Fibreoptic evaluation showed vocal cord abnormalities in 11% of the patients and severe tracheomalacia in one patient (2.6%). The authors conclude that there is a quantifi- The Griggs kit has previously been studied by Leonard et al 9 , who examined 49 patients surviving at least six months following percutaneous tracheostomy. Thirty-nine patients returned a questionnaire, 13 patients attended for review of the scar and spirometry and ten patients underwent flexible tracheoscopy. Fourteen patients (36%) had significant subjective complaints regarding voice change, cough and dyspnoea. All patients except one had a good or satisfactory scar and none had evidence of tracheal stenosis on spirometry or tracheoscopy. We concluded that the Griggs technique was comparable to other existing techniques and that it was unclear whether subjective or objective findings could be attributed to the tracheostomy itself, previous laryngeal intubation or other pre-existing problems.
Another group who studied the Griggs technique 22 evaluated twenty-five patients using a questionnaire and spiral CT. Forty four percent of patients reported 24 found tracheal stenosis of more than 10% in 12/19 (63%) of patients who underwent laryngotracheoscopy, however none of these patients had clinically relevant stenosis. They also showed that only 32% of tracheostomies were placed in the correct site between the first and second tracheal rings, a fact that may have contributed to their laryngoscopic findings.
We have chosen to use spirometry to assess upper airway obstruction as it is not invasive, easy to perform and provides data not available from static studies, such at CT. Tracheal stenosis is often defined as more than 10% reduction in diameter 15, 19, 21, 24 , but the clinical significance of this degree of stenosis is unclear. Many patients may apparently have some evidence of tracheal stenosis on testing, without it being symptomatic. We therefore consider that spirometry may reflect clinically significant dynamic upper airway obstruction more closely than static findings on imaging or laryngotracheoscopy. A previous study showed good correlation (although in a small sample size) between pulmonary function testing and direct airway visualization 9 . The fact that more patients complained of voice change and cough than had spirometric evidence of upper airway obstruction may be due to other factors, such as length and recurrent endotracheal intubation and concomitant heart or lung disease.
The literature regarding long-term follow-up of percutaneous tracheotomy is not extensive, reflecting the relative novelty of the technique. This may also reflect the difficulties and limitations which this and similar studies face. The major difficulty faced is the high level of "background noise" (i.e., how much does the period of translaryngeal intubation prior to tracheostomy contribute to the changes seen at follow-up?). How much do other ICU procedures impact on subsequent tracheal stenosis (e.g., patient movement, level of sedation, nursing and physiotherapy procedures, management of tracheostomy and endotracheal tube cuff pressures)? The ideal follow-up study would involve patients from the same ICU, one group who had a tracheostomy on admission to the ICU and the other group who were managed only with translaryngeal intubation regardless of length of ventilation. Clearly such a study would be neither practical nor ethical. In the meantime it would be useful to reach a consensus on the ideal time to perform such studies and the ideal method to detect tracheal stenosis.
In summary, our study shows good overall longterm results and an acceptable complication rate following percutaneous tracheostomy by the Griggs technique.
